153 results on '"Valery, Patricia C"'
Search Results
2. A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levels
3. Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists
4. Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort
5. Fitting Health Care to People: Understanding and Adapting to the Epidemiology and Health Literacy of People Affected by Viral Hepatitis from Culturally and Linguistically Diverse Migrant Backgrounds
6. Long-term Azithromycin in Children With Bronchiectasis Unrelated to Cystic Fibrosis: Treatment Effects Over Time
7. Aboriginal and Torres Strait Islander patients' cancer care pathways in Queensland: Insights from health professionals
8. Implementation of a nurse-delivered, community-based liver screening and assessment program for people with non-alcoholic fatty liver disease (LOCATE-NAFLD trial)
9. The Impact of Social Workers in Cirrhosis Care: a Systematic Review
10. Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes
11. Poor disease knowledge is associated with higher healthcare service use and costs among patients with cirrhosis: an exploratory study
12. Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up
13. Population‐level 5‐year event‐free survival for children with cancer in Australia.
14. Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA‐C).
15. Overcoming disparities in hepatocellular carcinoma outcomes in First Nations Australians: a strategic plan for action.
16. High prevalence of diabetes among young First Nations Peoples with metabolic dysfunction-associated steatotic liver disease: a population-based study in Australia
17. Australians with metabolic dysfunction‐associated steatotic liver disease have a twofold increase in the incidence of cancer.
18. Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care
19. Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care.
20. Diabetes mellitus and the progression of non‐alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort study
21. Predicting clinical outcomes in people with NAFLD: no need for a crystal ball?
22. Low Prevalence of Use of Allied Health and Community Services for Patients with Cirrhosis in Australia: A Need for Greater Engagement
23. Higher levels of supportive care needs are linked to higher health service use and cost, poor quality of life, and high distress in patients with cirrhosis in Queensland, Australia
24. Low Prevalence of Use of Allied Health and Community Services for Patients with Cirrhosis in Australia: A Need for Greater Engagement
25. A Discrete Choice Experiment to Elicit Preferences for a Liver Screening Programme in Queensland, Australia: A Mixed Methods Study to Select Attributes and Levels
26. “You feel different in your body”: Experiences of fatigue among children undergoing radiotherapy for cancer treatment
27. Low accuracy of FIB-4 test to identify people with diabetes at low risk of advanced fibrosis
28. Differences in the pattern and cost of hospital care between Indigenous and non‐Indigenous Australians with cirrhosis: an exploratory study
29. Partnering with support persons and clinicians to improve the health care experiences of patients with cirrhosis.
30. Differences in the pattern and cost of hospital care between Indigenous and non‐Indigenous Australians with cirrhosis: an exploratory study.
31. Targeted antiviral treatment of hepatitis B virus in culturally and linguistically diverse populations to achieve elimination targets in Australia
32. Towards collaborative management of non‐alcoholic fatty liver disease: a ‘real‐world’ pathway for fibrosis risk assessment in primary care
33. Childhood cancer survival and avoided deaths in Australia, 1983–2016
34. Epidemiology of ascites fluid infections in patients with cirrhosis in Queensland, Australia from 2008 to 2017
35. Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort
36. Patient‐oriented medication education intervention has long‐term benefits for people with decompensated cirrhosis
37. Changes in cancer incidence and survival among Aboriginal and Torres Strait Islander children in Australia, 1997–2016
38. Partnering with support persons and clinicians to improve the health care experiences of patients with cirrhosis
39. Additional file 1 of Poor disease knowledge is associated with higher healthcare service use and costs among patients with cirrhosis: an exploratory study
40. Additional file 1 of Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up
41. An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care.
42. Changes in cancer incidence and survival among Aboriginal and Torres Strait Islander children in Australia, 1997–2016
43. Bacteraemia, sepsis and antibiotic resistance in Australian patients with cirrhosis: a population-based study
44. Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety
45. Aboriginal and Torres Strait Islander patients’ cancer care pathways in Queensland: Insights from health professionals
46. Fitting Health Care to People: Understanding and Adapting to the Epidemiology and Health Literacy of People Affected by Viral Hepatitis from Culturally and Linguistically Diverse Migrant Backgrounds
47. Predicting Liver‐Related Outcomes in People With Nonalcoholic Fatty Liver Disease: The Prognostic Value of Noninvasive Fibrosis Tests
48. Disparities in Unmet Needs in Indigenous and Non-Indigenous Australians with Cirrhosis: An Exploratory Study
49. Childhood cancer survival and avoided deaths in Australia, 1983–2016.
50. Predicting Liver‐Related Outcomes in People With Nonalcoholic Fatty Liver Disease: The Prognostic Value of Noninvasive Fibrosis Tests.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.